MBF-015

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug NameMBF-015
Drug Alias NameMBF-015
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitorsHistone deacetylase 1 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 1
Therapy Area/IndicationsHuntington DiseaseNervous System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedibiofarma SL
China Registration ClassN/A

Develop Information

Active CompaniesMedibiofarma SL
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A